WASHINGTON – Proving disease modification of Alzheimer’s disease in a clinical drug trial may not be easy.
Some researchers developing drugs for treating Alzheimer’s disease hope to find a way to...
A diagnosis of diabetes in later life is associated with an increased risk of dementia, particularly in individuals with preexisting vascular disease.
A population-based matched cohort study in...
WASHINGTON – Age-related cognitive declines have a different presentation in women and in men.
As men age they show a steeper decline, compared with women, in their ability to name words from a...
WASHINGTON – A 3-month program of supervised aerobic exercise and strength training led to modest but statistically significant improvement in cognition in a pilot, single-center study that enrolled...
WASHINGTON – A 7-minute screening tool nearly doubled the rate at which primary care physicians could identify elderly patients in their practices with dementia in a German study involving more than...
Certain cerebrospinal fluid biomarkers may help differentiate Parkinson’s disease from other causes of parkinsonism and also predict which patients will later develop Parkinson’s-related dementia,...
Clinical outcomes of elderly patients treated with neoadjuvant chemoradiation (nCRT) for locally advanced rectal cancer (LARC) were similar enough to outcomes of younger patients that doctors may...
WASHINGTON – A randomized, double-blind, placebo-controlled trial has supported the purported cognitive boosting capability of the dietary supplement Alpha BRAIN. While the trial was small, it’s a...
WASHINGTON – For the first time, a randomized study has demonstrated that vigorous physical exercise not only improves cognition, but moves Alzheimer’s disease biomarkers in the right direction.
Six...
WASHINGTON – Daily treatment with a combined formulation of dextromethorphan and quinidine led to a significant and clinically meaningful cut in agitation episodes among patients with Alzheimer’s...
